AtheroGenics Reports Third Quarter 2008 Financial Results
ATLANTA, GA--(Marketwire - November 10, 2008) - AtheroGenics, Inc. (PINKSHEETS: AGIXQ), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today reported financial results for the third quarter and nine months ended September 30, 2008.